ENLIGHT-LN Trademark

Trademark Overview


On Friday, February 4, 2022, a trademark application was filed for ENLIGHT-LN with the United States Patent and Trademark Office. The USPTO has given the ENLIGHT-LN trademark a serial number of 97253196. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, March 13, 2024. This trademark is owned by Aurinia Pharmaceuticals Inc.. The ENLIGHT-LN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research services; medical research and development in the field of lupus nephritis; providing medical and scientific research information in the field of clinical trials; scientific research, namely, conducting clinical trials for others in the field of lupus nephritis
enlight-ln

General Information


Serial Number97253196
Word MarkENLIGHT-LN
Filing DateFriday, February 4, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, March 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2022

Trademark Statements


Pseudo MarkENLIGHTEN
Goods and ServicesMedical research services; medical research and development in the field of lupus nephritis; providing medical and scientific research information in the field of clinical trials; scientific research, namely, conducting clinical trials for others in the field of lupus nephritis

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 9, 2022
Primary Code042
First Use Anywhere DateMonday, November 30, 2020
First Use In Commerce DateMonday, November 30, 2020

Trademark Owner History


Party NameAurinia Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressVictoria, B.C. V8Z7X8
CA

Party NameAurinia Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressVictoria, B.C. V8Z7X8
CA

Trademark Events


Event DateEvent Description
Thursday, March 14, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 12, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 21, 2024USE AMENDMENT FILED
Monday, March 11, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 21, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, August 31, 2023ASSIGNED TO EXAMINER
Wednesday, August 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 21, 2023SOU EXTENSION 1 GRANTED
Monday, August 21, 2023SOU EXTENSION 1 FILED
Monday, August 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 17, 2022ASSIGNED TO EXAMINER
Wednesday, February 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 8, 2022NEW APPLICATION ENTERED